Dr Stephen Wong
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
87 Scholarly works
2 Projects
HIGHLIGHTS
2025
Journal article
Functional Characterization and a Real-World Clinical Laboratory Pilot of the Foundation for the National Institutes of Health Circulating Tumor DNA Quality Control Materials.
DOI: 10.1200/PO-25-002452021
Research grants (ARC, NHMRC, MRFF)
Defining the Plasma Methylome to Guide Melanoma Treatment.
2020
Research Grant
Novel Blood-Based Biomarkers to Guide Immunotherapy Management in Early Stage Melanoma
2019
Journal article
Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
DOI: 10.1038/s41591-018-0243-z2014
Journal article
Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: A virtual appliance approach for instant deployment
DOI: 10.1371/journal.pone.00952172013
Journal article
Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours
DOI: 10.1038/srep034942013
Journal article
BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage
DOI: 10.1158/1078-0432.CCR-13-0398
RECENT SCHOLARLY WORKS
2025
Journal article
Lung cancer biobanking in Australia: challenges and future directions
DOI: 10.5694/mja2.700122025
Journal article
Multi-omics evaluation of peritoneal fluid in gastroesophageal cancer (OMEGCA): protocol for a prospective multicentre cohort study to detect occult peritoneal metastases in patients undergoing curative-intent treatment
DOI: 10.1371/journal.pone.03186152025
Journal article
A non-randomised open-label exploratory ‘window of opportunity’ study of TG02 treatment in patients with locally advanced primary and recurrent RAS mutant colorectal cancer
DOI: 10.1016/j.heliyon.2024.e413642025
Journal article
Integrating Multi-Cancer Early Detection (MCED) Tests with Standard Cancer Screening: System Dynamics Model Development and Feasibility Testing
DOI: 10.1007/s41669-024-00533-32024
Journal article
Unravelling mutational signatures with plasma circulating tumour DNA
DOI: 10.1038/s41467-024-54193-22024
Journal article
A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE
DOI: 10.1038/s41467-024-46008-12024
Journal article
Plasma ctDNA enables early detection of temozolomide resistance mutations in glioma
DOI: 10.1093/noajnl/vdae0412024
Journal article
Plasma ctDNA liquid biopsy of IDH1, TERTp, and EGFRvIII mutations in glioma
DOI: 10.1093/noajnl/vdae027